Pioglitazone and Metformin
Sponsors
Takeda, Huazhong University of Science and Technology, Beni-Suef University
Conditions
Diabetes MellitusDiabetes Mellitus, Type 2DyslipidemiasPolycystic Ovarian Syndrome (PCOS)
Phase 3
Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.
CompletedNCT00727857
Start: 2007-06-30End: 2008-08-31Updated: 2011-07-29
Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.
CompletedNCT00770653
Start: 2007-04-30End: 2009-05-31Updated: 2010-10-06
Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes
CompletedNCT00772174
Start: 2007-01-31End: 2008-02-29Updated: 2010-07-05
Phase 4
Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes
CompletedNCT00754403
Start: 2005-07-31End: 2006-10-31Updated: 2010-07-05
Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.
CompletedNCT00770835
Start: 2009-03-31End: 2011-05-31Updated: 2011-07-12
Effectiveness and Safety of Adding Compound Preparation of Pioglitazone and Metformin for Type 2 Diabetic Patients
CompletedNCT02099838
Start: 2012-01-31End: 2013-12-31Updated: 2014-06-25
Unknown Phase
Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.
CompletedNCT00449553
Start: 2001-06-30End: 2003-09-30Updated: 2012-02-28
Enhancing PCOS Management for Better Outcomes of Intracytoplasmic Sperm Injection
Active, not recruitingNCT07604779
Start: 2026-05-17End: 2027-03-03Target: 150Updated: 2026-05-22